Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00464880
Status:
COMPLETED
Last Update Posted:
2007-11-29
First Post:
2007-04-21
Brief Title:
Effects of Aliskiren Irbesartan and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy
Sponsor:
Novartis
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CSPP100A2243
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None